Iovance Biotherapeutics, Inc. (IOVA)
3.56
-0.14
(-3.78%)
USD |
NASDAQ |
May 12, 16:00
3.57
+0.01
(+0.28%)
After-Hours: 07:48
Iovance Biotherapeutics Cash from Investing (Quarterly) : 11.39M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -1.188M |
| Anika Therapeutics, Inc. | -1.239M |
| BioCryst Pharmaceuticals, Inc. | -268.65M |
| Plus Therapeutics, Inc. | -1.077M |
| Perspective Therapeutics, Inc. | -109.55M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -72.07M |
| Cash from Financing (Quarterly) | 94.34M |
| Free Cash Flow | -305.02M |
| Free Cash Flow Per Share (Quarterly) | -0.188 |
| Free Cash Flow to Equity (Quarterly) | -77.01M |
| Free Cash Flow to Firm (Quarterly) | -78.68M |
| Free Cash Flow Yield | -22.49% |